Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain EW message board posts where the ticker symbol EW has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest EW SEC Filings

Filings Format Description Filing Date File/Film Number
8-K  Documents Current report, items 2.02 and 9.01
Acc-no: 0001099800-18-000027 (34 Act)  Size: 1 MB
2018-10-23 001-15525
181134407
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-014652 Size: 9 KB
2018-10-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-014651 Size: 6 KB
2018-10-16
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-014551 Size: 9 KB
2018-10-11
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-014477 Size: 8 KB
2018-10-09
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-013508 Size: 9 KB
2018-09-17
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-013402 Size: 9 KB
2018-09-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-013401 Size: 12 KB
2018-09-14
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-013252 Size: 13 KB
2018-09-07
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-013251 Size: 9 KB
2018-09-07
More EW SEC Filings


Related news from
Tue, 23 Oct 2018
20:34:21 +0000
Edwards Lifesciences: 3Q Earnings Snapshot
On a per-share basis, the Irvine, California-based company said it had profit of $1.06. Earnings, adjusted for one-time gains and costs, were $1.07 per share. The results exceeded Wall Street expectations. ...
Tue, 23 Oct 2018
20:15:00 +0000
Edwards Lifesciences Reports Third Quarter Results
IRVINE, Calif. , Oct. 23, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today ...
Tue, 23 Oct 2018
14:13:56 +0000
Dow Falls 400 Points As Market Correction Deepens; Centene Falters
The Dow Jones industrial average fell over 400 points on weak earnings results from Caterpillar and 3M. Top growth stock Centene faltered.
Tue, 23 Oct 2018
12:35:24 +0000
The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks None of the stocks hit 52-week highs in Monday's session. Down In The Dumps (Biotech stocks hitting 52-week ...
Tue, 23 Oct 2018
12:20:44 +0000
Edwards Lifesciences Q3 Earnings Preview
Don't be caught off-guard: Edwards Lifesciences Corporation (NYSE: EW ) releases its next round of earnings this Tuesday, Oct. 23. Want to skip the homework and get all the facts in one place? We thought ...
Tue, 23 Oct 2018
12:11:18 +0000
With A -8.3% Earnings Drop, Did Edwards Lifesciences Corporation (NYSE:EW) Really Underperform?
Examining Edwards Lifesciences Corporation’s (NYSE:EW) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations,<div><a class="permalink" href="https://simplywall.st/news/yahoo-post/with-a-8-3-earnings-drop-did-edwards-lifesciences-corporation-nyseew-really-underperform/">Read More...</a></div>
Tue, 23 Oct 2018
11:30:00 +0000
Edwards Comments On German Court Decision
IRVINE, Calif., Oct. 23, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced that today the district court in Düsseldorf, Germany, granted Boston Scientific's request for a preliminary injunction on future commercial sales and, therefore, patient treatments using the Edwards SAPIEN 3 Ultra valve in Germany.  The injunction will only become effective if Boston Scientific enforces it and provides a bond of €10 million.
Mon, 22 Oct 2018
19:03:24 +0000
Nasdaq Up; Will These 3 Sectors Lead A Market Turnaround?
Key stock indexes showed mixed action and reflected a continued battle between the bulls and bears. The Nasdaq led with a small gain.
Mon, 22 Oct 2018
15:39:03 +0000
EW, VAR Earnings Due on Oct 23: Here Are Key Predictions
Both Edwards Lifesciences (EW) and Varian Medical (VAR) are brimming with prospects despite the current political disarray within the medical instruments space.
Mon, 22 Oct 2018
12:42:12 +0000
Medidata (MDSO) Tops Earnings & Revenue Estimates in Q3
Strong performance in the Subscription revenues segment drives Medidata???s (MDSO) results in Q3. Professional services also posted steady growth.
Mon, 22 Oct 2018
12:33:12 +0000
Is a Surprise Coming for Edwards Lifesciences (EW) This Earnings Season?
Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Fri, 19 Oct 2018
21:45:09 +0000
Edwards Lifesciences (EW) Dips More Than Broader Markets: What You Should Know
Edwards Lifesciences (EW) closed the most recent trading day at $145.51, moving -1.23% from the previous trading session.
Fri, 19 Oct 2018
14:32:07 +0000
Gauging Analysts’ Views for NovoCure Stock
Of the five analysts covering NovoCure (NVCR) stock in October, two have given it a “strong buy,” and three have given it a “buy.” The mean rating for NovoCure is 1.6 with a target price of $56.50. That implies an upside potential of 24.4% over its trading price of $45.42 on October 18.
Fri, 19 Oct 2018
13:02:26 +0000
NovoCure’s Operational Performance in Q3 2018: What to Expect
NovoCure’s (NVCR) gross income is expected to rise 28.22% to $44.82 million in the third quarter of 2018. Its gross margin is expected to contract from 69.76% in the third quarter of fiscal 2017 to 68.7% in the third quarter of fiscal 2018. NovoCure’s gross margins for fiscal 2018 and fiscal 2019 are expected to be 67.97% and 72.72%, respectively.
Thu, 18 Oct 2018
12:05:01 +0000
See what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Thu, 18 Oct 2018
12:00:12 +0000
Will Edwards' (EW) Steady Overall Growth Drive Q3 Earnings?
Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q3.
Wed, 17 Oct 2018
18:51:06 +0000
Abbott (ABT) Q3 Earnings Top Estimates, Guidance Narrowed
Within Structural Heart, growth was driven by several product areas across Abbott's (ABT) broad portfolio, including AMPLATZER PFO Occluder and MitraClip.
Wed, 17 Oct 2018
15:57:58 +0000
Barclays Takes Action on Health Care Stocks
The firm has initiated coverage of Abbott Labs, Boston Scientific, Medtronic, Stryker and others
Wed, 17 Oct 2018
11:00:11 +0000
Bear of the Day: Newmont Mining (NEM)
Bear of the Day: Newmont Mining (NEM)



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is the gold standard, valuable because of the exceptional people who post here, and because the best of them are candid, detailed and informed. There is little tolerance for the b.s. found on public boards, and management and members are vigilant and aggressive about TOS violations. VF is the gold standard." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards